Time-limited Trials
Time-Limited Trials is a clinical decision-making framework in intensive care that establishes a predefined period during which aggressive medical interventions are provisionally continued to objectively assess treatment responsiveness, with a plan for reassessment and potential withdrawal of life-sustaining therapies if predefined goals are not met.
34
Publications
1.8K
Citations
180
Authors
103
Institutions
Publications per year
2017–2026
14
34
Time-Limited Trials Near the End of Life
Timothy E. Quill, Robert G. Holloway · JAMA · 2011 · 273 citations
Zebrafish as animal model for aquaculture nutrition research
Pilar E. Ulloa · Frontiers in Genetics · 2014 · 121 citations · Full text
Dong Chang, Thanh H. Neville, Jennifer Parrish et al. · JAMA Internal Medicine · 2021 · 117 citations · Full text
1–5 of 34
180
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 180
103
University of Rochester Medical Center
Rochester, United States
3 h-index
7 publications
561 citations
Yale University
New Haven, United States
3 h-index
6 publications
230 citations
Erasmus MC
Rotterdam, The Netherlands
3 h-index
6 publications
296 citations
Harvard University
Cambridge, United States
3 h-index
10 publications
689 citations
University of California, Los Angeles
Los Angeles, United States
2 h-index
6 publications
638 citations
Massachusetts General Hospital
Boston, United States
2 h-index
3 publications
163 citations
University of Cambridge
Cambridge, United Kingdom
2 h-index
6 publications
453 citations

Icahn School of Medicine at Mount Sinai
New York, United States
2 h-index
2 publications
168 citations
1–8 of 103
2 publications · 59 citations
2
h-index
AJOG · 2 publications · 157 citations
2
h-index
JSEP · 1 publications · 18 citations
1
h-index
1 publications · 16 citations
1
h-index
1 publications · 12 citations
1
h-index
1–5